7 articles, transcripts, and reports
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q1 2023 Earnings Call dated May. 03, 2023 Corporate participants: Atabak Mokari — Chief Financial Officer Charlie Robb — Chief…
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2022 Earnings Call dated Feb. 28, 2023. Corporate Participants: Atabak Mokari — Chief Financial Officer Charles Robb — Chief Business Officer Joseph Belanoff, MD — Chief…
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Atabak Mokari — CFO Joseph Belanoff — CEO Sean Maduck — President of Endocrinology Bill Guyer — Chief Development…
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q4 2021 earnings call dated Feb. 15, 2022 Corporate Participants: Atabak Mokari — Chief Financial Officer Charles Robb — Chief Business Officer Joseph Belanoff — Chief…
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q3 2021 earnings call dated Nov. 03, 2021 Corporate Participants: Atabak Mokari — Chief Financial Officer Charles Robb — Chief Business Officer Joseph K.…
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q4 2020 earnings call dated Feb. 08, 2021 Corporate Participants: Charles Robb — Chief Financial Officer Joseph K. Belanoff — Chief Executive Officer, President,…
Corcept Therapeutics Incorporated (CORT) Q1 2020 earnings call dated May 04, 2020 Corporate Participants: Charles Robb — Chief Financial Officer Joseph K Belanoff — Chief Executive Officer, President and…
